Publicacións nas que colabora con Francisco Barros Angueira (11)
2024
-
Genetic linkage analysis of head and neck cancer in a Spanish family
Oral Diseases, Vol. 30, Núm. 3, pp. 1032-1039
2020
-
Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?
Journal of Chemotherapy, pp. 1-13
2019
-
Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment
Head and Neck, Vol. 41, Núm. 8, pp. 2704-2715
2015
-
P21Waf1/CIP1 is a poor diagnostic and prognostic marker for OSCC although its expression increases in patients with N1 regional metastasis
Cancer Biomarkers, Vol. 15, Núm. 1, pp. 19-26
2014
-
Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients
Oncology Reports, Vol. 31, Núm. 4, pp. 1677-1682
2012
-
X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients
International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 1, pp. 138-144
2004
-
Association of PDCD1 with susceptibility to systemic lupus erythematosus: Evidence of population-specific effects
Arthritis and Rheumatism, Vol. 50, Núm. 8, pp. 2590-2597
2003
-
CARD15/NOD2 analysis in rheumatoid arthritis susceptibility
Rheumatology, Vol. 42, Núm. 11, pp. 1380-1382
-
Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease
Journal of Rheumatology, Vol. 30, Núm. 1, pp. 102-104
-
The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus
Rheumatology, Vol. 42, Núm. 4, pp. 570-574